Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.
Curiosity-driven basic science in the 1970s laid the groundwork for today’s leading vaccines against the novel coronavirus.
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.
At MIT Forefront, panelists discuss health care and work during a pandemic — and the role for business where government falls short.
Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.
Sequential immunization might be safer and more effective than the existing tetravalent vaccine.
The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.
The startup macro-eyes uses artificial intelligence to improve vaccine delivery and patient scheduling.